The World Health Organization has released its much-awaited guidance on best practices for clinical trials, which addresses challenges such as poor trial design, limited diversity of participants, insufficient infrastructure and bureaucratic efficiencies that cost time, money and lives.
Key Takeaways
-
The WHO has issued new guidance to improve the design, conduct and oversight of clinical trials in countries of all income levels.
The 76-page WHO guidance offers recommendations for national health authorities, regulatory authorities, researchers, funders and others on how they...